Treatment of Relapsed AML With Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion

This registry-based study compares survival in patients with acute myelogenous leukemia who have undergone a second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion after relapse.

https://ift.tt/2L74F2A